SIO CAPITAL MANAGEMENT, LLC
Adviser information for SIO CAPITAL MANAGEMENT, LLC last updated from Form ADV on March 26th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Liability Company |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 14 |
|---|---|
| Investment Advisory/Research | 7 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | Yes |
|---|
| Type | Accounts | RAUM |
|---|---|---|
| Discretionary | 7 | $1.4B |
| Non-Discretionary | 0 | $0 |
| Total | 7 | $1.4B |
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 2 | $709.7M |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 5 | $696.2M |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 43 |
Services
| Advisory Services | Portfolio management for pooled investment vehiclesPortfolio management for businesses or institutional clients |
|---|---|
| Compensation | % of AUMPerformance-based fees |
| Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
600 THIRD AVENUE2ND FLOOR
NEW YORK
NY
United States
Monday - Friday, 9 AM - 5 PM
Tel: 212-601-9792, Fax: None
Websites
Chief Compliance Officer
JIN LEE
600 THIRD AVENUE
2ND FLOOR
NEW YORK
NY
United States
Tel:
212-601-9792
J******@*************M
(Full email address available in API data)
Regulatory Contact
JUDAH DRILLICK
CHIEF EXECUTIVE OFFICER
600 THIRD AVENUE
2ND FLOOR
NEW YORK
NY
United States
Tel:
212-601-9787
J*************@*************M
(Full email address available in API data)
Industry Affiliates
| SIO GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| SIO PARTNERS OFFSHORE, LTD. | Hedge Fund | $278.0M | $1.0M | 35 |
| SIO PARTNERS, LP | Hedge Fund | $431.7M | $1.0M | 73 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| CASTOR, MICHAEL, BERNARD | Individual | – | MANAGING MEMBER | 03/2006 | > 75% |
| DRILLICK, JUDAH, ZVI | Individual | – | CHIEF EXECUTIVE OFFICER | 07/2015 | < 5% |
| LEE, JIN, WOO | Individual | – | CHIEF COMPLIANCE OFFICER | 02/2021 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| ABBOTT LABORATORIES | COM | 9M | 90K | – |
| ANI PHARMACEUTICALS INC | COM | 5M | 72K | – |
| APOGEE THERAPEUTICS INC | COM | 3M | 78K | – |
| APREA THERAPEUTICS INC | COM NEW | 1M | 277K | – |
| ARCUTIS BIOTHERAPEUTICS INC | COM | 1M | 160K | – |
| ASLAN PHARMACEUTICALS LTD | SPON ADS NEW | 76K | 254K | – |
| ASTRIA THERAPEUTICS INC | COM | 5M | 510K | – |
| AVALO THERAPEUTICS INC | COM NEW | 891K | 71K | – |
| BRIDGEBIO PHARMA INC | COM | 3M | 125K | – |
| BIODESIX INC | COM | 7M | 4M | – |
| BAUSCH PLUS LOMB CORP | COMMON SHARES | 4M | 303K | – |
| BOUNDLESS BIO INC | COM | 627K | 162K | – |
| THE CIGNA GROUP | COM | 9M | 27K | – |
| CAREMAX INC | *W EXP 06/08/202 | 200 | 13K | – |
| COMPASS PATHWAYS PLC | SPONSORED ADS | 2M | 293K | – |
| CONTEXT THERAPEUTICS INC | COM | 3M | 1M | – |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 10M | 225K | – |
| ENANTA PHARMACEUTICALS INC | COM | 2M | 177K | – |
| ERASCA INC | COM | 7M | 3M | – |
| FOGHORN THERAPEUTICS INC. | COM | 700K | 122K | – |
| GSK PLC | SPONSORED ADR | 12M | 312K | – |
| HUMACYTE INC | *W EXP 08/27/202 | 70K | 50K | – |
| INSMED INC | COM PAR $.01 | 91M | 1M | – |
| DISC MEDICINE INC | COM | 9M | 192K | – |
| KENVUE INC | COM | 9M | 485K | – |
| LABCORP HOLDINGS INC | COM SHS | 50M | 246K | – |
| MODULAR MED INC | COM NEW | 2M | 2M | – |
| NUVATION BIO INC | COM CL A | 2M | 668K | – |
| NEXTCURE INC | COM | 207K | 130K | – |
| NYXOAH S A | SHS | 354K | 51K | – |
| ORGANON & CO | COMMON STOCK | 13M | 608K | – |
| PACIRA BIOSCIENCES INC | COM | 13M | 456K | – |
| PMV PHARMACEUTICALS INC | COM | 4M | 3M | – |
| PRELUDE THERAPEUTICS INC | COM | 1M | 320K | – |
| RAPT THERAPEUTICS INC | COM | 961K | 315K | – |
| ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 29K | 400K | – |
| SMITH & NEPHEW PLC | SPDN ADR NEW | 14M | 580K | – |
| ARS PHARMACEUTICALS INC | COM | 2M | 218K | – |
| STOKE THERAPEUTICS INC | COM | 2M | 175K | – |
| TELEFLEX INCORPORATED | COM | 23M | 111K | – |
| THIRD HARMONIC BIO INC | COM | 2M | 163K | – |
| TYRA BIOSCIENCES INC | COM | 10M | 600K | – |
| VERASTEM INC | COM NEW | 398K | 133K | – |
| VENTYX BIOSCIENCES INC | COM | 2M | 779K | – |
| VAXART INC | COM NEW | 10M | 15M | – |
| X4 PHARMACEUTICALS INC | COM | 1M | 2M | – |
| ZIMMER BIOMET HOLDINGS INC | COM | 17M | 155K | – |
| ZYMEWORKS INC | COM | 4M | 491K | – |